View Grant Opportunity
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
National Institutes of Health
PAR-26-134
HHS-NIH11
General Information
N/a
Est. Program Funding:
Est. Program Funding:
November 22, 2028
Closing Date:
Closing Date:
N/a
Expected No. of Awards
Expected No. of Awards
$500,000
Award Ceiling
Award Ceiling
Opportunity Number:
PAR-26-134
Owning Agency:
HHS-NIH11
Opportunity Category:
Discretionary (D)
Synopsis
| The National Cancer Institute's (NCI) Metastasis Research Network (MetNet) is a collection of U54 Research Centers that support using systems-level approaches to understand pressing questions in metastasis. The overall goal of the MetNet is to advance our understanding of metastasis as a whole body, systems-level problem to develop a comprehensive and cohesive picture of the processes involved. Through this Notice of Funding Opportunity (NOFO), the NCI invites applications for MetNet Research Projects. These Research Projects should be defined as discrete entities that use systems-level approaches to address gaps and opportunities in metastasis research to integrate into the MetNet and complement ongoing research across the Network. | |
| Response Date | Nov 22, 2028 12:00:00 AM EST |
| Posting Date | Feb 04, 2026 12:00:00 AM EST |
| Archive Date | Jan 22, 2029 12:00:00 AM EST |
| Award Ceiling | 500,000 |
| Award Floor | N/a |
| Cost Sharing | No |
Eligibility
| Eligible Applicants | For profit organizations other than small businesses, State governments, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, County governments, Public housing authorities/Indian housing authorities, Public and State controlled institutions of higher education, Private institutions of higher education, Small businesses, Special district governments, Independent school districts, City or township governments, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Native American tribal governments (Federally recognized), Others (see text field entitled "Additional Information on Eligibility" for clarification) |
| Additional Info on Eligibility: | Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. This new requirement was effective, May 1, 2025.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors. |
Additional Information
| Agency Name | National Institutes of Health |
| Link to Additional Information: | N/a |
| Grantor Contact Information: |
If you have difficulty accessing the full announcement electronically, please contact:
GrantSolutions Help Desk Phone: 301-402-2541 |
CFDA Program(s)
- 93.396: Cancer Biology Research
Contact Us
Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.